Login / Signup

The problem of look-alike, sound-alike name errors: Drivers and solutions.

Rachel BryanJeffrey K AronsonAlison WilliamsSusan Jordan
Published in: British journal of clinical pharmacology (2020)
Look-alike or sound-alike (LASA) medication names may be mistaken for each other, e.g. mercaptamine and mercaptopurine. If an error of this sort is not intercepted, it can reach the patient and may result in harm. LASA errors occur because of shared linguistic properties between names (phonetic or orthographic), and potential for error is compounded by similar packaging, tablet appearance, tablet strength, route of administration or therapeutic indication. Estimates of prevalence range from 0.00003 to 0.0022% of all prescriptions, 7% of near misses, and between 6.2 and 14.7% of all medication error events. Solutions to LASA errors can target people or systems, and include reducing interruptions or distractions during medication administration, typographic tweaks, such as selective capitalization (Tall Man letters) or boldface, barcoding, and computerized physician order entry.
Keyphrases
  • adverse drug
  • emergency department
  • patient safety
  • healthcare
  • electronic health record
  • primary care
  • risk factors
  • drug induced
  • human health
  • quality improvement
  • risk assessment
  • climate change